1. Home
  2. ATOS vs DHX Comparison

ATOS vs DHX Comparison

Compare ATOS & DHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • DHX
  • Stock Information
  • Founded
  • ATOS 2009
  • DHX 1991
  • Country
  • ATOS United States
  • DHX United States
  • Employees
  • ATOS N/A
  • DHX N/A
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • DHX Business Services
  • Sector
  • ATOS Health Care
  • DHX Consumer Discretionary
  • Exchange
  • ATOS Nasdaq
  • DHX Nasdaq
  • Market Cap
  • ATOS 130.5M
  • DHX 143.1M
  • IPO Year
  • ATOS 2012
  • DHX 2007
  • Fundamental
  • Price
  • ATOS $1.00
  • DHX $2.15
  • Analyst Decision
  • ATOS Strong Buy
  • DHX Strong Buy
  • Analyst Count
  • ATOS 3
  • DHX 2
  • Target Price
  • ATOS $6.25
  • DHX $5.25
  • AVG Volume (30 Days)
  • ATOS 1.3M
  • DHX 410.2K
  • Earning Date
  • ATOS 11-11-2025
  • DHX 11-11-2025
  • Dividend Yield
  • ATOS N/A
  • DHX N/A
  • EPS Growth
  • ATOS N/A
  • DHX N/A
  • EPS
  • ATOS N/A
  • DHX N/A
  • Revenue
  • ATOS N/A
  • DHX $134,396,000.00
  • Revenue This Year
  • ATOS N/A
  • DHX N/A
  • Revenue Next Year
  • ATOS N/A
  • DHX N/A
  • P/E Ratio
  • ATOS N/A
  • DHX N/A
  • Revenue Growth
  • ATOS N/A
  • DHX N/A
  • 52 Week Low
  • ATOS $0.55
  • DHX $1.21
  • 52 Week High
  • ATOS $1.66
  • DHX $3.34
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 60.15
  • DHX 31.52
  • Support Level
  • ATOS $0.86
  • DHX $1.99
  • Resistance Level
  • ATOS $1.29
  • DHX $2.97
  • Average True Range (ATR)
  • ATOS 0.08
  • DHX 0.17
  • MACD
  • ATOS 0.01
  • DHX -0.09
  • Stochastic Oscillator
  • ATOS 43.16
  • DHX 17.56

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About DHX DHI Group Inc.

DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.

Share on Social Networks: